WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia: Abbisko Therapeutics Deepens R&D Collaboration with Lilly — Warptech Lab News

Storia in 4 fonti

Abbisko Therapeutics Deepens R&D Collaboration with Lilly

Abbisko Therapeutics Deepens R&D Collaboration with Lilly

Raccontata da

morningstar.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo1 mese fa

Abbisko Therapeutics Deepens R&D Collaboration with Lilly

Abbisko Therapeutics Deepens R&D Collaboration with Lilly

benzinga.com1 mese fa

Eli Lilly, Abbisko Expand Drug Hunt With $1.9 Billion Research Pact - Eli Lilly (NYSE:LLY)

Abbisko Therapeutics signed a new Eli Lilly partnership worth up to $1.9 billion to develop novel medicines globally.

Leggi questa versione → originale

Timeline cronologica

mercoledì 24 giugno 2026·forbes.com
Abbisko Teams Up With Lilly In Latest U.S.-China Pharma Collaboration
Strategic research collaboration and license agreement is worth up to $1.9 billion to Abbisko
mercoledì 24 giugno 2026·morningstar.com
Abbisko Therapeutics Deepens R&D Collaboration with Lilly
Abbisko Therapeutics Deepens R&D Collaboration with Lilly

forbes.com1 mese fa

Abbisko Teams Up With Lilly In Latest U.S.-China Pharma Collaboration

Strategic research collaboration and license agreement is worth up to $1.9 billion to Abbisko

Leggi questa versione → originale

endpoints.news1 mese fa

Lilly offers up to $1.9B in new drug discovery deal with Abbisko

Building on a pact from 2022, Eli Lilly has signed a new discovery collaboration with Abbisko Therapeutics that could see it pay the Chinese biotech up to $1.9 billion.

Leggi questa versione → originale

mercoledì 24 giugno 2026·

endpoints.news

Lilly offers up to $1.9B in new drug discovery deal with Abbisko

Building on a pact from 2022, Eli Lilly has signed a new discovery collaboration with Abbisko Therapeutics that could see it pay the Chinese biotech up to $1.9 billion.

mercoledì 24 giugno 2026·

benzinga.com

Eli Lilly, Abbisko Expand Drug Hunt With $1.9 Billion Research Pact - Eli Lilly (NYSE:LLY)

Abbisko Therapeutics signed a new Eli Lilly partnership worth up to $1.9 billion to develop novel medicines globally.